1. Overlapping conditions in Long COVID at a multisite academic center
- Author
-
Stephanie L. Grach, Daniel V. Dudenkov, Beth Pollack, DeLisa Fairweather, Chris A. Aakre, Bala Munipalli, Ivana T. Croghan, Michael R. Mueller, Joshua D. Overgaard, Katelyn A. Bruno, Nerissa M. Collins, Zhuo Li, Ryan T. Hurt, Michal C. Tal, Ravindra Ganesh, and Dacre T. R. Knight
- Subjects
SARS-CoV-2 ,generalized joint hypermobility ,myalgic encephalomyelitis/chronic fatigue syndrome ,hypermobile Ehlers-Danlos syndrome ,orthostatic intolerance ,pain ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundMany patients experience persistent symptoms after COVID-19, a syndrome referred to as Long COVID (LC). The goal of this study was to identify novel new or worsening comorbidities self-reported in patients with LC.MethodsPatients diagnosed with LC (n = 732) at the Mayo Long COVID Care Clinic in Rochester, Minnesota and Jacksonville, Florida were sent questionnaires to assess the development of new or worsening comorbidities following COVID-19 compared to patients with SARS-CoV-2 that did not develop LC (controls). Both groups were also asked questions screening for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), generalized joint hypermobility (GJH) and orthostatic intolerance. 247 people with LC (33.7%) and 40 controls (50%) responded to the surveys.ResultsIn this study LC patients averaged 53 years of age and were predominantly White (95%) women (75%). The greatest prevalence of new or worsening comorbidities following SARS-CoV-2 infection in patients with LC vs. controls reported in this study were pain (94.4% vs. 0%, p
- Published
- 2024
- Full Text
- View/download PDF